Swiss Lions 100 | Provisional 2026 edition

Novartis

Novartis is No. 4 in the Swiss Lions 100 and No. 2 in Life Sciences & Health, with a score of 78.1 out of 100. Headquarters: Basel, canton of Basel-Stadt.

Swiss Lions score
78.1
Overall rank
4of 100
Life Sciences & Health
2of 14

About

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.

From Wikipedia, licensed under CC BY-SA 4.0.

How the score is made

Global scale

90

CHF 45.8bn revenue.

Swiss value

60

Swiss made: Partly.

Prominence

70.5

Wikipedia attention across language editions, and Google search interest.

Impact

70

Net-zero target validated. Not a certified B Corp.

Philanthropy

20

Corporate foundation: Novartis Foundation.

How the ranking works.

Key figures

Revenue used in the ranking
CHF 45.8bnTTM Oct 2026, company
Revenue
USD 56.7bnTwelve months to 30 June 2026
Net profit
USD 12.8bnAttributable to shareholders
Dividends paid
USD 9.1bnTo all shareholders
Employees worldwide
75,267

Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.

Profile

Headquarters
BaselCanton of Basel-Stadt
Language region
German-speaking
Formed
1996Merger of Ciba-Geigy and Sandoz

Nearby in the Swiss Lions 100

Also in Life Sciences & Health

See all 14 brands in Life Sciences & Health.

Sources

  • Revenue used in the ranking: stockanalysis.com NOVN (TTM Oct 2026).
  • Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
  • Climate target: Science Based Targets initiative dashboard, October 2026.
  • Foundations: Swiss commercial register (Zefix). B Corp: B Lab directory.
  • Prominence: Wikimedia page views (October 2025 to September 2026) and Google Trends.
  • Founded and website: Wikidata.
  • Logo: Wikimedia Commons: Novartis-Logo-2023.svg. Logos are trademarks of their owners.

Something out of date?

If a figure is wrong, or Novartis can publish figures for the next edition, tell us. Corrections are recorded with their source.

Scroll to Top